EHRA 2019: Wait‑And‑See Vs. Acute Cardioversion In Recent‑Onset AF

Prof Harry Crijns (Maastricht University Medical Center, Maastricht, NL) discusses the 'Wait-and-See versus Acute Cardioversion trial in Recent-Onset AF patients' with his colleagues Dr Elton Dudink and Dr Nikki Pluymaekers who conducted the trial.
Filmed on site at EHRA 2019 by Radcliffe Cardiology
Questions:
1. What is the rationale for this study?
2. What was the design of the trial?
3. What was the endpoint of the study and why?
4. Was the wait-and-see approach effective?
5. Did you see any complications?
6. Was the wait-and-see approach safe?
7. Was the wait-and-see approach cost-effective?
8. What are the implications for clinical practice?
9. Was the wait-and-see approach effective?
10.Are further studies planned?
Videographers: Tom Green & Mike Knight
Education Lead: Dr Harry Crijns
See more videos here : www.radcliffec...
radcliffecardiology.com is a dynamic, digitally-focused producer & publisher of Cardiovascular, Renal and Metabolic (CVRM) content for physicians worldwide. Radcliffe Cardiology also has a dedicated eLearning platform, RC Academy, which uses innovative platforms to host digital webinars, live case broadcasts and video roundtable discussions.
RC Academy : www.radcliffec...